Legal Representation
Attorney
Lisa Greenwald-Swire
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 26, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 26, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 29, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 28, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 26, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 26, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 7, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 7, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 7, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 6, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 6, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 6, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Feb 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 28, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 23, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 21, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 21, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 21, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 13, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 13, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 24, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 22, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 22, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 22, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 21, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 24, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 24, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 4, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 19, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 14, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 6, 2016 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 6, 2016 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 29, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 29, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 29, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 29, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 19, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 19, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 23, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical therapeutic agents for the treatment of cancer, autoimmune disease and immunologic-based disease; Full line of pharmaceutical preparations for the prevention or treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical products, namely, diagnostic reagents for medical purposes; Control reagents for medical laboratory purposes; Control reagents for clinical medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005